Abstract:Yarrowia lipolytica is a novel microbial chassis to upgrade renewable low-cost carbon feedstocks to high-value commodity chemicals and natural products. In this work, we systematically characterized and removed the rate-limiting steps of the shikimate pathway and achieved de novo synthesis of five aromatic chemicals in Y. lipolytica. We determined that eliminating amino acids formation and engineering feedback-insensitive DAHP synthases are critical steps to mitigate precursor competition and relieve the feedback regulation of the shikimate pathway. Further overexpression of heterologous phosphoketolase and deletion of pyruvate kinase provided a sustained metabolic driving force that channels E4P (erythrose 4-phosphate) and PEP (phosphoenolpyruvate) precursors through the shikimate pathway. Precursor competing pathways and byproduct formation pathways were also blocked by inactivating chromosomal genes. To demonstrate the utility of our engineered chassis strain, three natural products, 2-phenylethanol (2-PE), p-coumaric acid, and violacein, which were derived from phenylalanine, tyrosine, and tryptophan, respectively, were chosen to test the chassis performance. We obtained 2426.22 ± 48.33 mg/L of 2-PE, 593.53 ± 28.75 mg/L of p-coumaric acid, 12.67 ± 2.23 mg/L of resveratrol, 366.30 ± 28.99 mg/L of violacein, and 55.12 ± 2.81 mg/L of deoxyviolacein from glucose in a shake flask. The 2-PE production represents a 286-fold increase over the initial strain (8.48 ± 0.50 mg/L). Specifically, we obtained the highest 2-PE, violacein, and deoxyviolacein titer ever reported from the de novo shikimate pathway in yeast. These results set up a new stage of engineering Y. lipolytica as a sustainable biorefinery chassis strain for de novo synthesis of aromatic compounds with economic values.This article has not yet been cited by other publications.

Chassis and Key Enzymes Engineering for Monoterpenes Production.

Advances in Metabolic Engineering of Saccharomyces Cerevisiae for Terpenoids Biosynthesis

Metabolic engineering of microbes for monoterpenoid production

Advances in the Metabolic Engineering of Escherichia Coli for the Manufacture of Monoterpenes

Chassis Engineering for Microbial Production of Chemicals: from Natural Microbes to Synthetic Organisms.

[Microbial synthesis of monoterpenoids: a review].

Compartmentalization Engineering of Yeasts to Overcome Precursor Limitations and Cytotoxicity in Terpenoid Production

Repurposing the cellulase workhorse Trichoderma reesei as a ROBUST chassis for efficient terpene production

A “push-pull-restrain” strategy to improve citronellol production in Saccharomyces cerevisiae

Advances in Metabolic Engineering Paving the Way for the Efficient Biosynthesis of Terpenes in Yeasts

[Enzyme engineering in microbial biosynthesis of terpenoids: progress and perspectives].

Modularly engineering Rhodotorula toruloides for α-terpineol production

Metabolic Engineering Strategies for Sustainable Terpenoid Flavor and Fragrance Synthesis

Building Streptomyces albus as a Chassis for Synthesis of Bacterial Terpenoids

Plasticity engineering of plant monoterpene synthases and application for microbial production of monoterpenoids

Systematic Engineering to Enhance β-Myrcene Production in Yeast

Strategies, Achievements, and Potential Challenges of Plant and Microbial Chassis in the Biosynthesis of Plant Secondary Metabolites

Synthesis of myrcene using a hybrid cell-free reaction system

Recent Advances and Multiple Strategies of Monoterpenoid Overproduction in Saccharomyces cerevisiae and Yarrowia lipolytica

Unified Enantiospecific Synthesis of Drimane Meroterpenoids Enabled by Enzyme Catalysis and Transition Metal Catalysis

Engineering Yarrowia lipolytica as a Chassis for De Novo Synthesis of Five Aromatic-Derived Natural Products and Chemicals